Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension.
Simonneau, Gérald
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension. [electronic resource] - The European respiratory journal Oct 2012 - 874-80 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
1399-3003
10.1183/09031936.00137511 doi
Acetamides--therapeutic use
Administration, Oral
Adult
Aged
Familial Primary Pulmonary Hypertension
Female
Humans
Hypertension, Pulmonary--drug therapy
Male
Middle Aged
Pyrazines--therapeutic use
Receptors, Epoprostenol
Receptors, Prostaglandin--agonists
Treatment Outcome
Vascular Resistance--drug effects
Vasodilator Agents--therapeutic use
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension. [electronic resource] - The European respiratory journal Oct 2012 - 874-80 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
1399-3003
10.1183/09031936.00137511 doi
Acetamides--therapeutic use
Administration, Oral
Adult
Aged
Familial Primary Pulmonary Hypertension
Female
Humans
Hypertension, Pulmonary--drug therapy
Male
Middle Aged
Pyrazines--therapeutic use
Receptors, Epoprostenol
Receptors, Prostaglandin--agonists
Treatment Outcome
Vascular Resistance--drug effects
Vasodilator Agents--therapeutic use